I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Viteri, Santiago
291
results:
Search for persons
X
Format
Online (291)
Mediatypes
Articles (Online) (107)
Bookchapter (Online) (4)
OpenAccess-fulltext (180)
Languages
english (203)
spanish (46)
Sorted by: Relevance
Sorted by: Year
?
1
Recommendations for reporting tissue and circulating tumour..:
Malapelle, Umberto
;
Leighl, Natasha
;
Addeo, Alfredo
...
British Journal of Cancer. 131 (2024) 2 - p. 212-219 , 2024
Link:
https://doi.org/10.1038/..
?
2
A brief report on stable disease among amivantamab-treated ..:
Girard, Nicolas
;
Park, Keunchil
;
Lee, Se-Hoon
...
Cancer Treatment and Research Communications. 40 (2024) - p. 100832 , 2024
Link:
https://doi.org/10.1016/..
?
3
PPD01.01 ctDNA Dynamics, Prognostic Markers and Resistance ..:
Le, Xiuning
;
Garassino, Marina Chiara
;
Ahn, Myung-Ju
...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e4 , 2024
Link:
https://doi.org/10.1016/..
?
4
Fluorescence In Situ Hybridization (FISH) for the Character..:
Román-Lladó, Ruth
;
Aguado, Cristina
;
Jordana-Ariza, Núria
...
Journal of Molecular Pathology. 4 (2023) 1 - p. 57-68 , 2023
Link:
https://doi.org/10.3390/..
?
5
An Adjusted Treatment Comparison Comparing Amivantamab Vers..:
Chouaid, Christos
;
Bosquet, Lise
;
Girard, Nicolas
...
Advances in Therapy. 40 (2023) 3 - p. 1187-1203 , 2023
Link:
https://doi.org/10.1007/..
?
6
Liquid biopsy, big data and artificial intelligence as a ne..:
Abad, Albert
;
Vidal, Joana
;
Layos, Laura
...
The Journal of Liquid Biopsy. 1 (2023) - p. 100008 , 2023
Link:
https://doi.org/10.1016/..
?
7
Olaparib maintenance versus placebo in platinum-sensitive n..:
Postel-Vinay, Sophie
;
Coves, Juan
;
Texier, Matthieu
...
British Journal of Cancer. 130 (2023) 3 - p. 417-424 , 2023
Link:
https://doi.org/10.1038/..
?
8
Detecting ALK, ROS1, and RET fusions and the METΔex14 splic..:
Giménez‐Capitán, Ana
;
Sánchez‐Herrero, Estela
;
Robado de Lope, Lucía
...
Molecular Oncology. 17 (2023) 9 - p. 1884-1897 , 2023
Link:
https://doi.org/10.1002/..
?
9
ONCOS-102 plus pemetrexed and platinum chemotherapy in mali..:
Ponce, Santiago
;
Cedrés, Susana
;
Ricordel, Charles
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 9 - p. e007552 , 2023
Link:
https://doi.org/10.1136/..
?
10
Tepotinib in patients with non-small cell lung cancer with ..:
Le, Xiuning
;
Paz-Ares, Luis G.
;
Van Meerbeeck, Jan
...
Cell Reports Medicine. 4 (2023) 11 - p. 101280 , 2023
Link:
https://doi.org/10.1016/..
?
11
Author Correction: BIM and mTOR expression levels predict o..:
Karachaliou, Niki
;
Codony-Servat, Jordi
;
Teixidó, Cristina
...
Scientific Reports. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
12
Plain language summary of the development of tepotinib: a t..:
Hallick, John
;
Baird, Anne-Marie
;
Falchook, Gerald
...
Future Oncology. 19 (2023) 10 - p. 683-696 , 2023
Link:
https://doi.org/10.2217/..
?
13
Amivantamab compared with real-world therapies in patients ..:
Minchom, Anna
;
Viteri, Santiago
;
Bazhenova, Lyudmila
...
Lung Cancer. 168 (2022) - p. 74-82 , 2022
Link:
https://doi.org/10.1016/..
?
14
Safety of MET Tyrosine Kinase Inhibitors in Patients With M..:
Cortot, Alexis
;
Le, Xiuning
;
Smit, Egbert
...
Clinical Lung Cancer. 23 (2022) 3 - p. 195-207 , 2022
Link:
https://doi.org/10.1016/..
?
15
Frequency, underdiagnosis, and heterogeneity of epidermal g..:
Viteri, Santiago
;
Minchom, Anna
;
Bazhenova, Lyudmila
...
Molecular Oncology. 17 (2022) 2 - p. 230-237 , 2022
Link:
https://doi.org/10.1002/..
1-15